CVS 2010 Annual Report Download - page 10

Download and view the complete annual report

Please find page 10 of the 2010 CVS annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 82

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82

We’ve taken a leadership role in pharmacogenomic
testing and clinical services.
Through our majority stake in Generation Health, we plan to make genetic
benefit management an integral part of our PBM offering. The emerging field
of pharmacogenomics focuses on providing the right drug and dosage to the
right patient. By identifying how an individual’s genetic variations are likely to
impact his or her response to a particular treatment, we can minimize adverse
drug reactions and avoid wasted drug spend. The market for targeted therapies
is expected to reach $21 billion by 2015. We’re currently testing the efficacy
of 13 drug therapies, and initiatives such as these are truly advancing the
science of pharmacy care.
is this
Kim’s DNA Test R esult
- or -
An Exciting Treatment Breakthrough
?
– 6 –
CVS Caremark 2010 Annual Report